Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
OpenAI expands ads manager to U.K., adds CPC
Similar to the U.S. the ads manager is now widely available in the U.K., and is the fifth market where advertisers can access it.
How Fanatics moved from audience targeting to optimizing campaigns for customer LTV
A recent 19% lift in LTV points to brands focus on outcome-based media buying.
As AI scrutiny grows, DUDE Wipes points to supply chain savings and productivity gains
AI may be facing an ROI reckoning. Brands, agencies and tech vendors alike are starting to face harder questions about whether generative AI can deliver the meaningful business results it promises. The honeymoon phase, however, isn’t over yet. DUDE Wipes has AI tools across the company, reducing man hours in supply chain tasks — providing employees […]